Publications

Publications récentes

Voir les publications précédentes

1^er septembre 2000

The yeast two-hybrid system and its pharmaceutical significance.

Topcu Z, Borden K
Pharm. Res. 2000-09-01 ;17( 9 ):1049-55
1^er septembre 2000

Glucocorticoid-inducible retrovector for regulated transgene expression in genetically engineered bone marrow stromal cells.

Jaalouk DE, Eliopoulos N, Couture C, Mader S, Galipeau J
Hum. Gene Ther. 2000-09-01 ;11( 13 ):1837-49
1^er septembre 2000

Reply: beyond receptor dimerization

Angers S, Bouvier M
Trends Pharmacol. Sci. 2000-09-01 ;21( 9 ):326
1^er septembre 2000

In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions.

Melnick A, Ahmad KF, Arai S, Polinger A, Ball H, Borden K, Carlile GW, Prive GG, Licht JD
Mol. Cell. Biol. 2000-09-01 ;20( 17 ):6550-67
1^er août 2000

SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression.

Herblot S, Steff AM, Hugo P, Aplan PD, Hoang T
Nat. Immunol. 2000-08-01 ;1( 2 ):138-44
1^er août 2000

NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis.

Salehi AH, Roux PP, Kubu CJ, Zeindler C, Bhakar A, Tannis LL, Verdi JM, Barker PA
Neuron 2000-08-01 ;27( 2 ):279-88
1^er août 2000

p38 MAP kinase pathway regulates angiotensin II-induced contraction of rat vascular smooth muscle.

Meloche S, Landry J, Huot J, Houle F, Marceau F, Giasson E
Am. J. Physiol. Heart Circ. Physiol. 2000-08-01 ;279( 2 ):H741-51
20 juillet 2000

Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis.

Yen L, You XL, Al Moustafa AE, Batist G, Hynes NE, Mader S, Meloche S, Alaoui-Jamali MA
Oncogene 2000-07-20 ;19( 31 ):3460-9

Voir plus de publications

Publications

The yeast two-hybrid system and its pharmaceutical significance.

Glucocorticoid-inducible retrovector for regulated transgene expression in genetically engineered bone marrow stromal cells.

Reply: beyond receptor dimerization

In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions.

SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression.

NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis.

p38 MAP kinase pathway regulates angiotensin II-induced contraction of rat vascular smooth muscle.

Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis.